ECEun-Young Karen Choi

Eun-Young Karen Choi

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Eun-Young Karen Choi has a total of 69 co-authors. Here are the top co-authors by number of shared publications:

  • Rajiv M. Patel

    Department of Dermatology University of Michigan Ann Arbor Michigan USA

    4 shared publications
  • Henry D. Appelman

    Department of Pathology, University of Michigan, 5220 Medical Science I, 1301 Catherine Street, SPC 5602, Ann Arbor, MI 48109-5602, USA

    3 shared publications
  • Dafydd G. Thomas

    Department of Pathology, University of Michigan, Ann Arbor, Michigan

    2 shared publications
  • Darren D. Ballard

    Darren D Ballard, Division of Gastroenterology and Hepatology, Medical College of Wisconsin, Milwaukee, WI 53226, United States

    2 shared publications
  • David R Lucas

    Department of Pathology, University of Michigan, Ann Arbor, MI, USA

    2 shared publications
  • David R. Lucas

    Department of Pathology, University of Michigan, 3261G Medical Science I, 1301 Catherine St, SPC 5602, Ann Arbor, Michigan 48109

    2 shared publications

Latest Publications

  • Open Access

    Detection of Hepatocellular Carcinoma in an Orthotopic Patient-Derived Xenograft with an Epithelial Cell Adhesion Molecule-Specific Peptide

    by Xiaoli Wu, Shuo Feng, Tse-Shao Chang, Ruoliu Zhang, Sangeeta Jaiswal, Eun-Young K. Choi, Yuting Duan, Hui Jiang, Thomas D. Wang

    Hepatocellular carcinoma (HCC) has emerged as a major contributor to the worldwide cancer burden. Improved methods are needed for early cancer detection and image-guided surgery. Peptides have small dimensions that can overcome delivery challenges to achieve high tumor concentrations and deep penetration. We used phage display methods to biopan against the extra-cellular domain of the purified EpCAM protein, and used IRDye800 as a near-infrared (NIR) fluorophore. The 12-mer sequence HPDMFTRTHSHN was identified, and specific binding to EpCAM was validated with HCC cells in vitro. A binding affinity of kd = 67 nM and onset of k = 0.136 min−1 (7.35 min) were determined. Serum stability was measured with a half-life of T1/2 = 2.6 h. NIR fluorescence images showed peak uptake in vivo by human HCC patient-derived xenograft (PDX) tumors at 1.5 h post-injection. Also, the peptide was able to bind to foci of local and distant metastases in liver and lung. Peptide biodistribution showed high uptake in tumor versus other organs. No signs of acute toxicity were detected during animal necropsy. Immunofluorescence staining of human liver showed specific binding to HCC compared with cirrhosis, adenoma, and normal specimens.


  • Open Access

    The Perfect Storm: An Unusual Cause of Intestinal Perforation in a Solid Organ Transplant Patient

    by Karan Joseph, Daniel Aintabi, Eun-Young K. Choi, Jeffrey A. Berinstein

    Ach and cecum, despite early discontinuation of mycophenolate mofetil—the most likely culprit medication. The ongoing injury observed despite holding mycophenolate suggests a possible compounding effect of tacrolimus and everolimus. Both these agents are underrepresented causes of GI injury. This perfect storm of agents may have accounted for the severity and extensive presentation observed in our patient....


  • Open Access

    Hepatocyte-specific loss of LAP2α protects against diet-induced hepatic steatosis and steatohepatitis in male mice

    by Kapil K. Upadhyay, Eun-Young K. Choi, Roland Foisner, M. Bishr Omary, Graham F. Brady

    There is increasing evidence for the importance of the nuclear envelope in lipid metabolism, nonalcoholic fatty liver disease (NAFLD), and nonalcoholic steatohepatitis (NASH). Human mutations in LMNA , encoding A-type nuclear lamins, cause early-onset insulin resistance and NASH, while hepatocyte-specific deletion of Lmna predisposes to NASH with fibrosis in male mice. Given that variants in the gene encoding LAP2α, a nuclear protein that regulates lamin A/C, were previously identified in patients with NAFLD, we sought to determine the role of LAP2α in NAFLD using a mouse genetic model. Hepatocyte-specific Lap2a-knockout ( Lap2α (ΔHep) ) mice and littermate controls were fed normal chow or high-fat diet (HFD) for 8 weeks or 6 months. In contrast to what was observed with hepatocyte-specific Lmna deletion, male Lap2a (ΔHep) mice showed no increase in hepatic steatosis or NASH compared to controls. Rather, Lap2a (ΔHep) mice demonstrated reduced hepatic steatosis, particularly after long-term HFD, with decreased susceptibility to diet-induced NASH. Accordingly, whereas pro-steatotic genes Cidea, Mogat1 , and Cd36 were upregulated in Lmnα -KO mice, they were downregulated in Lap2α (ΔHep) mice, and there was a trend toward decreases in pro-inflammatory and pro-fibrotic genes. These data indicate that hepatocyte-specific Lap2a deletion protects against hepatic steatosis and NASH in mice; therefore, LAP2α might represent a potential therapeutic target in human NASH. Brief Summary: Loss of LAP2α in mouse hepatocytes protected against diet-induced hepatic steatosis and NASH.


  • 825 ONCOGENIC POTENTIAL OF DYSPLASTIC STEM CELLS IN GASTRIC CARCINOGENESIS

    by Jimin Min, Sophie Camilleri-Broet, Hyuk-Joon Lee, Han-Kwang Yang, James R. Goldenring, Eunyoung Choi

  • Chronic Colitis in Biopsy Samples

    by Eun-Young Karen Choi, Henry D. Appelman


  • The utility of ETV1, ETV4 and ETV5 RNA in‐situ hybridization in the diagnosis of CIC–DUX sarcomas

    by Steven C Smith, Nallasivam Palanisamy, Elizabeth Martin, Jorge Almenara, Jonathan B McHugh, Eun‐Young K Choi, David R Lucas, Bryan L Betz, Dafydd Thomas, Rajiv M Patel

    Aims: A recently characterized group of undifferentiated small round cell sarcomas harbours fusions of the genes CIC and DUX4. Studies report a distinctive gene expression profile for these sarcomas, including expression of E26 transformation‐specific (ETS) family proto‐oncogenic transcription factors ETV1, ETV4 and ETV5. To test the utility of an ancillary diagnostic technique for these tumours, we evaluated chromogenic RNA in‐situ hybridization assays for ETV1, ETV4 and ETV5 as diagnostic adjuncts for this emerging group of highly malignant sarcomas.Methods and results: We tested six confirmed CIC–DUX4 sarcomas and 105 lesions in the differential, including 48 Ewing sarcomas for expression of ETV1, ETV4 and ETV5, scoring expression utilizing a previously validated scale. ETV1 and ETV4 were positive in five of six cases, while ETV5 was positive in six of six. No Ewing sarcoma or other sarcoma tested showed coexpression of these transcripts, while one ETV1/ETV4/ETV5 triple positive previously unclassified round cell sarcoma was identified as harbouring a CIC rearrangement by break‐apart fluorescence in‐situ hybridization (FISH).Conclusion: We identified overexpression of ETV1, ETV4 and ETV5 transcripts in situ in CIC–DUX4 sarcomas using a robust assay in routine archival sections. One previously unclassified round cell sarcoma showed ETV1/4/5 positivity, and was proved to harbour a CIC rearrangement by break‐apart FISH. The sensitivity and specificity observed with our in‐situ hybridization assay implies potential utility as an ancillary diagnostic technique, particularly when faced with limited biopsy samples.


  • A Historical Perspective and Exposé on Serrated Polyps of the Colorectum

    by Eun-Young Karen Choi, Henry D. Appelman

    This article offers a historical perspective on the discovery of 3 types of serrated colorectal polyps recognized in the past 60 years. The first to be discovered was the hyperplastic polyp, which is still the most commonly encountered serrated polyp. In the past 20 years, the carcinoma-associated sessile serrated adenoma/polyp has been recognized, but its diagnosis can be difficult owing to overlapping histologic features with hyperplastic polyps. Less is known about the third type, the traditional serrated adenoma, because it is far less common than the other 2 types, and its association with cancer is currently under investigation.


  • Deletion of Men1 and somatostatin induces hypergastrinemia and gastric carcinoids

    by Sinju Sundaresan, Anthony J Kang, Michael M Hayes, Eun-Young K Choi, Juanita L Merchant

    Background: Gastric carcinoids are slow growing neuroendocrine tumours arising from enterochromaffin-like (ECL) cells in the corpus of stomach. Although most of these tumours arise in the setting of gastric atrophy and hypergastrinemia, it is not understood what genetic background predisposes development of these ECL derived tumours. Moreover, diffuse microcarcinoids in the mucosa can lead to a field effect and limit successful endoscopic removal. Objective: To define the genetic background that creates a permissive environment for gastric carcinoids using transgenic mouse lines. Design: The multiple endocrine neoplasia 1 gene locus (Men1) was deleted using Cre recombinase expressed from the Villin promoter (Villin-Cre) and was placed on a somatostatin null genetic background. These transgenic mice received omeprazole-laced chow for 6 months. The direct effect of gastrin and the gastrin receptor antagonist YM022 on expression and phosphorylation of the cyclin inhibitor p27 Kip1 was tested on the human human gastric adenocarcinoma cell line stably expressing CCKBR (AGSE) and mouse small intestinal neuroendocrine carcinoma (STC)-1 cell lines. Results: The combination of conditional Men1 deletion in the absence of somatostatin led to the development of gastric carcinoids within 2 years. Suppression of acid secretion by omeprazole accelerated the timeline of carcinoid development to 6 months in the absence of significant parietal cell atrophy. Carcinoids were associated with hypergastrinemia, and correlated with increased Cckbr expression and nuclear export of p27 Kip1 both in vivo and in gastrin-treated cell lines. Loss of p27 Kip1 was also observed in human gastric carcinoids arising in the setting of atrophic gastritis. Conclusions: Gastric carcinoids require threshold levels of hypergastrinemia, which modulates p27 Kip1 cellular location and stability.


  • Open Access

    Outcomes of submucosal (T1b) esophageal adenocarcinomas removed by endoscopic mucosal resection

    by Darren D Ballard, Neel Choksi, Jingmei Lin, Eun-Young Choi, B Joseph Elmunzer, Henry Appelman, Douglas K Rex, Hala Fatima, William Kessler, John M DeWitt

    Outcomes of submucosal (T1b) esophageal adenocarcinomas removed by endoscopic mucosal resection